Literature DB >> 34091197

A situational awareness Bayesian network approach for accurate and credible personalized adaptive radiotherapy outcomes prediction in lung cancer patients.

Yi Luo1, Shruti Jolly2, David Palma3, Theodore S Lawrence2, Huan-Hsin Tseng2, Gilmer Valdes4, Daniel McShan2, Randall K Ten Haken2, Issam Ei Naqa2.   

Abstract

PURPOSE: A situational awareness Bayesian network (SA-BN) approach is developed to improve physicians' trust in the prediction of radiation outcomes and evaluate its performance for personalized adaptive radiotherapy (pART).
METHODS: 118 non-small-cell lung cancer patients with their biophysical features were employed for discovery (n = 68) and validation (n = 50) of radiation outcomes prediction modeling. Patients' important characteristics identified by radiation experts to predict individual's tumor local control (LC) or radiation pneumonitis with grade ≥ 2 (RP2) were incorporated as expert knowledge (EK). Besides generating an EK-based naïve BN (EK-NBN), an SA-BN was developed by incorporating the EK features into pure data-driven BN (PD-BN) methods to improve the credibility of LC or / and RP2 prediction. After using area under the free-response receiver operating characteristics curve (AU-FROC) to assess the joint prediction of these outcomes, their prediction performances were compared with a regression approach based on the expert yielded estimates (EYE) penalty and its variants.
RESULTS: In addition to improving the credibility of radiation outcomes prediction, the SA-BN approach outperformed the EYE penalty and its variants in terms of the joint prediction of LC and RP2. The value of AU-FROC improves from 0.70 (95% CI: 0.54-0.76) using EK-NBN, to 0.75 (0.65-0.82) using a variant of EYE penalty, to 0.83 (0.75-0.93) using PD-BN and 0.83 (0.77-0.90) using SA-BN; with similar trends in the validation cohort.
CONCLUSIONS: The SA-BN approach can provide an accurate and credible human-machine interface to gain physicians' trust in clinical decision-making, which has the potential to be an important component of pART.
Copyright © 2021 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Accuracy and credibility; Bayesian networks; Personalized adaptive radiotherapy; Situational awareness

Mesh:

Year:  2021        PMID: 34091197      PMCID: PMC8284560          DOI: 10.1016/j.ejmp.2021.05.032

Source DB:  PubMed          Journal:  Phys Med        ISSN: 1120-1797            Impact factor:   3.119


  31 in total

1.  Unraveling biophysical interactions of radiation pneumonitis in non-small-cell lung cancer via Bayesian network analysis.

Authors:  Yi Luo; Issam El Naqa; Daniel L McShan; Dipankar Ray; Ines Lohse; Martha M Matuszak; Dawn Owen; Shruti Jolly; Theodore S Lawrence; Feng-Ming Spring Kong; Randall K Ten Haken
Journal:  Radiother Oncol       Date:  2017-02-22       Impact factor: 6.280

2.  A multiobjective Bayesian networks approach for joint prediction of tumor local control and radiation pneumonitis in nonsmall-cell lung cancer (NSCLC) for response-adapted radiotherapy.

Authors:  Yi Luo; Daniel L McShan; Martha M Matuszak; Dipankar Ray; Theodore S Lawrence; Shruti Jolly; Feng-Ming Kong; Randall K Ten Haken; Issam El Naqa
Journal:  Med Phys       Date:  2018-06-04       Impact factor: 4.071

3.  Suggestion for a new grading scale for radiation induced pneumonitis based on radiological findings of computerized tomography: correlation with clinical and radiotherapeutic parameters in lung cancer patients.

Authors:  Vassilios Kouloulias; Anna Zygogianni; Efstathios Efstathopoulos; Oikonomopoulou Victoria; Antypas Christos; Karaiskos Pantelis; Vassilios Koutoulidis; John Kouvaris; Panagiotis Sandilos; Maria Varela; Ilknur Aytas; Athanasios Gouliamos; Nikolaos Kelekis
Journal:  Asian Pac J Cancer Prev       Date:  2013

4.  Development of a Fully Cross-Validated Bayesian Network Approach for Local Control Prediction in Lung Cancer.

Authors:  Yi Luo; Daniel McShan; Dipankar Ray; Martha Matuszak; Shruti Jolly; Theodore Lawrence; Feng Ming Kong; Randall Ten Haken; Issam El Naqa
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2018-05-02

5.  Plasma Levels of IL-8 and TGF-β1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation Study.

Authors:  Shulian Wang; Jeff Campbell; Matthew H Stenmark; Jing Zhao; Paul Stanton; Martha M Matuszak; Randall K Ten Haken; Feng-Ming Spring Kong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-03-14       Impact factor: 7.038

6.  Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma.

Authors:  Jeffrey D Bradley; Nantaken Ieumwananonthachai; James A Purdy; Todd H Wasserman; Mary Ann Lockett; Mary V Graham; Carlos A Perez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-01-01       Impact factor: 7.038

7.  Personalized treatment planning with a model of radiation therapy outcomes for use in multiobjective optimization of IMRT plans for prostate cancer.

Authors:  Wade P Smith; Minsun Kim; Clay Holdsworth; Jay Liao; Mark H Phillips
Journal:  Radiat Oncol       Date:  2016-03-11       Impact factor: 3.481

8.  Systematic assessment of the clinicopathological prognostic significance of tissue cytokine expression for lung adenocarcinoma based on integrative analysis of TCGA data.

Authors:  Yuanmei Dong; Yang Liu; Hui Bai; Shunchang Jiao
Journal:  Sci Rep       Date:  2019-04-19       Impact factor: 4.379

9.  Expert-augmented machine learning.

Authors:  Efstathios D Gennatas; Jerome H Friedman; Lyle H Ungar; Romain Pirracchio; Eric Eaton; Lara G Reichmann; Yannet Interian; José Marcio Luna; Charles B Simone; Andrew Auerbach; Elier Delgado; Mark J van der Laan; Timothy D Solberg; Gilmer Valdes
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-18       Impact factor: 11.205

10.  Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy.

Authors:  Cory Pierson; Taras Grinchak; Casey Sokolovic; Brandi Holland; Teresa Parent; Mark Bowling; Hyder Arastu; Paul Walker; Andrew Ju
Journal:  Radiat Oncol       Date:  2018-02-27       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.